R. D. Levin

Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study

D. J. Wallace, M. Pétri, Kyriakos A. Kirou et al. · Annals of the Rheumatic Diseases · 2011 · 228 citations

Pharmacy, Immunology, Pharmacology +17

Circadian function in patients with advanced non-small-cell lung cancer

R. D. Levin, M. Daehler, James F. Grutsch et al. · British Journal of Cancer · 2005 · 118 citations · Full text

Nursing, Health Sciences, Oncology +17

Comparison of the Effects of Restricted Morning or Evening Water Intake on Adrenocortical Activity in Female Rats

Gary D. Gray, Assar Bergfors, R. D. Levin et al. · Neuroendocrinology · 2008 · 48 citations

Life Sciences, Endocrinology, Physiology +17

The Role of Improved Water Quality on Inflammatory Markers in Patients Undergoing Regular Dialysis

Margaret A. Rahmati, Peter Homel, Nicholas A. Hoenich et al. · The International Journal of Artificial Organs · 2004 · 44 citations

Medicine, Nephrology, Dialysis +16

Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study

Daniel Burge, June Eisenman, Kelly Byrnes-Blake et al. · Lupus · 2016 · 41 citations

Life Sciences, Immunology, Pharmacology +17